Radioactive iodine therapy (RAIT) in N1 papillary thyroid cancer: Are we overtreating?

Files

Authors

Elizabeth Odil, Beaumont Health Resident
Jordan Reilly, Beaumont Health Resident
Fionna Sun
Diane Studzinski, Beaumont Health
Rose E. Callahan, Beaumont Health
Sapna Nagar, Beaumont Health

Publication Date

4-28-2022

Disciplines

Laboratory and Basic Science Research | Surgery

Recommended Citation

Odil E, Reilly J, Sun F, Studzinski D, Callahan R, Nagar S. Radioactive iodine therapy (RAIT) in N1 papillary thyroid cancer: are we overtreating. Poster presented at: The William Beaumont Hospital Royal Oak/Troy/Grosse Pointe 50th Annual Residents and Fellows Research Forum; 2022 April 28; Royal Oak, MI.

Comments

The William Beaumont Hospital Royal Oak/Troy/Grosse Pointe 50th Annual Residents and Fellows Research Forum, Royal Oak, Michigan, April 28, 2022.

68th Annual Meeting of the Michigan Chapter of the American College of Surgeons, Traverse City, Michigan, May 17-20, 2022